A Technological Breakthrough for Sex Determination in Hens’ Eggs
BayPAT presents the first non-invasive method
Bayerische Patentallianz GmbH
At present, approximately 100 million chicks per year are incubated in breeding facilities in Germany. Given that they are unable to lay eggs, male chicks are culled immediately after hatching. In Germany, up to 50 million chicks meet this fate every year. In contrast, ORBEM GENUS enables the sex of chicks to be determined during the early days of incubation. This means that the eggs containing male animals can be used for other purposes before the chicks have to experience any form of pain. Furthermore, the fact that half of the eggs laid only have to be incubated for few instead of 21 days means that breeding facilities can use their breeding equipment with higher efficiency.
Another advantage arises in the case of non-fertilised eggs, which represent around 15 percent of all eggs incubated. With ORBEM GENUS, these eggs can automatically be identified before incubation and passed on to the retail market, for example to be sold as table eggs.
BayPAT presents the first non-invasive method for sex determination in hens’ eggs: The new method, which has been given the name ORBEM GENUS, combines magnetic resonance imaging known from the world of medicine with cutting edge artificial intelligence, representing a fundamental innovative leap compared to the current technology available. Use of this photo is only authorised and free of charge within the context of the text contained in this press release. The source of the image must be credited. Any other use of the photo is excluded. Use of this image for editorial purposes is free of charge. In the case of publication, please cite the source as follows: “Bayerische Patentallianz GmbH”
The inventors
ORBEM GENUS was developed by lecturers and researchers at the Technical University of Munich (TUM). The brains behind the technology come from the specialist fields of Physics (Prof. Dr Axel Haase), Reproductive Biotechnology (Prof. Dr Benjamin Schusser, Dr. Maria Laparidou), and Bioengineering/Bioinformatics (Dr. Pedro Gómez, M.Sc. Miguel Molina). The team is planning to found a spin-off, which will also involve the acquisition of public funding and private venture capital, in order to further develop the new technology and make it ready for the market. BayPAT will advise, accompany and support the inventors on every step along the way.
Other news from the department science
Get the food & beverage industry in your inbox
From now on, don't miss a thing: Our newsletter for the food & beverage sector brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.